114 related articles for article (PubMed ID: 19628469)
1. Myocardial fibrosis in thalassaemia: recalling the past or telling the future?
Carpenter JP; Prasad SK; Pennell DJ
Heart; 2009 Oct; 95(20):1646-7. PubMed ID: 19628469
[No Abstract] [Full Text] [Related]
2. MRI and iron-overload cardiomyopathy in thalassaemia.
Pennell D
Circulation; 2006 Mar; 113(11):f43-4. PubMed ID: 16552847
[No Abstract] [Full Text] [Related]
3. Iron chelation therapy for non-transfusion-dependent thalassemia (NTDT): a status quo.
Taher AT; Musallam KM; Viprakasit V; Porter JB; Cappellini MD
Blood Cells Mol Dis; 2014; 52(2-3):88-90. PubMed ID: 24041597
[No Abstract] [Full Text] [Related]
4. Iron overload in transfusion-dependent thalassemia.
Saliba A; Taher A
Hematology; 2015 Jun; 20(5):311-2. PubMed ID: 25967377
[No Abstract] [Full Text] [Related]
5. Iron overload in thalassaemia intermedia: reassessment of iron chelation strategies.
Taher A; Hershko C; Cappellini MD
Br J Haematol; 2009 Dec; 147(5):634-40. PubMed ID: 19681884
[TBL] [Abstract][Full Text] [Related]
6. Australian guidelines for the assessment of iron overload and iron chelation in transfusion-dependent thalassaemia major, sickle cell disease and other congenital anaemias.
Ho PJ; Tay L; Lindeman R; Catley L; Bowden DK
Intern Med J; 2011 Jul; 41(7):516-24. PubMed ID: 21615659
[TBL] [Abstract][Full Text] [Related]
7. [Post-transfusional iron overload, iron loading anemia].
Rose C
Rev Med Interne; 2012 Jun; 33 Suppl 1():S15-8. PubMed ID: 22475955
[No Abstract] [Full Text] [Related]
8. MRI monitoring of myocardial iron overload: use of cardiac MRI combined with hepatic MRI in a cohort of multi-transfused patients with thalassaemia.
Quatre A; Jacquier A; Petit P; Giorgi R; Thuret I
Diagn Interv Imaging; 2014 Nov; 95(11):1065-9. PubMed ID: 25001363
[TBL] [Abstract][Full Text] [Related]
9. Left ventricular non-compaction in identical twins with thalassaemia and cardiac iron overload.
Luckie M; Irwin B; Nair S; Greenwood J; Khattar R
Eur J Echocardiogr; 2009 Jun; 10(4):509-12. PubMed ID: 19091793
[TBL] [Abstract][Full Text] [Related]
10. Assessment and treatment of cardiac iron overload in thalassemia.
Aessopos A; Farmakis D; Andreopoulos A; Tsironi M
Hemoglobin; 2009; 33 Suppl 1():S87-92. PubMed ID: 20001638
[TBL] [Abstract][Full Text] [Related]
11. Deferasirox for the treatment of iron overload in non-transfusion-dependent thalassemia.
Taher AT; Temraz S; Cappellini MD
Expert Rev Hematol; 2013 Oct; 6(5):495-509. PubMed ID: 24083402
[TBL] [Abstract][Full Text] [Related]
12. T2* magnetic resonance and myocardial iron in thalassemia.
Pennell DJ
Ann N Y Acad Sci; 2005; 1054():373-8. PubMed ID: 16339685
[TBL] [Abstract][Full Text] [Related]
13. Effect of deferiprone on liver iron overload and fibrosis in hepatitis-C-virus-infected thalassemia.
Chen AC; Peng CT; Wu SF; Wu KH; Chiang IP; Tsai CH
Hemoglobin; 2006; 30(2):209-14. PubMed ID: 16798645
[TBL] [Abstract][Full Text] [Related]
14. Understanding iron overload: screening, monitoring, and caring for patients with transfusion-dependent anemias.
Ault P; Jones K
Clin J Oncol Nurs; 2009 Oct; 13(5):511-7. PubMed ID: 19793708
[TBL] [Abstract][Full Text] [Related]
15. Post-transfusional iron overload in the haemoglobinopathies.
Thuret I
C R Biol; 2013 Mar; 336(3):164-72. PubMed ID: 23643400
[TBL] [Abstract][Full Text] [Related]
16. Profile of deferasirox for the treatment of patients with non-transfusion-dependent thalassemia syndromes.
Ricchi P; Marsella M
Drug Des Devel Ther; 2015; 9():6475-82. PubMed ID: 26719673
[TBL] [Abstract][Full Text] [Related]
17. An update on disordered iron metabolism and iron overload.
Ward R
Hematology; 2010 Oct; 15(5):311-7. PubMed ID: 20863426
[TBL] [Abstract][Full Text] [Related]
18. Deferasirox and children: From clinical trials to the real world.
Origa R; Zappu A; Foschini ML; Leoni G; Morittu M; Moi P; Corpino M; Dessì C
Am J Hematol; 2016 Jun; 91(6):E304-5. PubMed ID: 26950047
[No Abstract] [Full Text] [Related]
19. Myocardial iron overload assessed by magnetic resonance imaging (MRI)T2* in multi-transfused patients with thalassemia and acquired anemias.
Fragasso A; Ciancio A; Mannarella C; Gaudiano C; Scarciolla O; Ottonello C; Francone M; Nardella M; Peluso A; Melpignano A; Veglio MR; Quarta G; Turchetti C
Eur J Intern Med; 2011 Feb; 22(1):62-5. PubMed ID: 21238896
[TBL] [Abstract][Full Text] [Related]
20. Increasing prevalence of thalassemia in America: Implications for primary care.
Sayani FA; Kwiatkowski JL
Ann Med; 2015; 47(7):592-604. PubMed ID: 26541064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
